Patents by Inventor Pau Herrero VINAS

Pau Herrero VINAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11923063
    Abstract: There is provided apparatus for controlling the delivery of insulin to a subject. The apparatus comprises a first input (18) for receiving neural information from the subject indicative of prospective or actual food and/or drink intake and a second input (15) for receiving a signal indicative of the subject's blood glucose level (BG). The apparatus further comprises a processor or processors (10) configured to determine food and/or drink characteristics based on the received neural information and to determine an amount of insulin to be delivered based on the measured blood glucose levels (BG) and the determined food and/or drink characteristics, and an output for providing an insulin pump control signal (12) indicative of the determined amount of insulin.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: March 5, 2024
    Assignee: Imperial College Innovations Limited
    Inventors: Pantelis Georgiou, Amparo Güemes Gonzalez, Pau Herrero-Viñas
  • Patent number: 11826547
    Abstract: A method of adaptively determining one or more compensation factors in a closed-loop insulin delivery system comprising a continuous glucose level sensor, an insulin pump, and an insulin reservoir, where the system determines an insulin meal bolus taking into account an estimated amount of carbohydrates to be ingested, CHO, a difference between a currently sensed glucose level, G, and a glucose set point, Gsp, and at least one compensation factor, ICR.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: November 28, 2023
    Assignee: Imperial College Innovations Limited
    Inventors: Pau Herrero Vinas, Pantelis Georgiou, Nick Oliver, Christofer Toumazou
  • Publication number: 20210390399
    Abstract: The present disclosure relates to the prediction of physiological parameters, such as glucose levels. A training input is received, the training input comprising time-series values of a physiological parameter and time-series values of one or more further parameters. Training examples are generated form the training input, wherein each training example comprises a training dataset and a corresponding training label, wherein each training dataset is generated from the training input with time-series values restricted to a time interval, and wherein each corresponding training label represents the value of the physiological parameter a prediction period after the end of that time interval. A neural network is then trained using the training examples.
    Type: Application
    Filed: November 1, 2019
    Publication date: December 16, 2021
    Applicant: Imperial College of Science, Technology & Medicine
    Inventors: Pantelis GEORGIOU, Pau HERRERO-VINAS, Kezh LI
  • Publication number: 20190192774
    Abstract: A method of adaptively determining one or more compensation factors in a closed-loop insulin delivery system comprising a continuous glucose level sensor, an insulin pump, and an insulin reservoir, where the system determines an insulin meal bolus taking into account an estimated amount of carbohydrates to be ingested, CHO, a difference between a currently sensed glucose level, G, and a glucose set point, Gsp, and at least one compensation factor, ICR.
    Type: Application
    Filed: July 27, 2017
    Publication date: June 27, 2019
    Inventors: Pau Herrero VINAS, Pantelis GEORGIOU, Nick OLIVER, Christofer TOUMAZOU
  • Patent number: 9283323
    Abstract: The present invention relates to a controller unit and methods for controlling an insulin pump. The controller unit includes a user input that receives a gain factor. The gain factor has been calculated based on historical data in relation to a patient. The controller unit includes a measurement input for receiving data representative of a measured blood glucose level for the patient. Processing logic of the controller unit is configured to apply the measured blood glucose level to a pancreatic beta-cell insulin secretion computational model to predict an insulin output level, apply the gain factor to the predicted insulin output level to determine a patient insulin deficiency level, and calculate a control signal for controlling the insulin output level of the insulin pump based on the patient insulin deficiency level. Methods are provided for optimizing the gain factor based on the historical data in relation to the patient.
    Type: Grant
    Filed: August 9, 2012
    Date of Patent: March 15, 2016
    Assignee: GENE ONYX LIMITED
    Inventors: Christofer Toumazou, Pantelis Georgiou, Pau Herrero Vinas, Calvin Sim
  • Publication number: 20130041343
    Abstract: The present invention relates to a controller unit and methods for controlling an insulin pump. The controller unit includes a user input that receives a gain factor. The gain factor has been calculated based on historical data in relation to a patient. The controller unit includes a measurement input for receiving data representative of a measured blood glucose level for the patient. Processing logic of the controller unit is configured to apply the measured blood glucose level to a pancreatic beta-cell insulin secretion computational model to predict an insulin output level, apply the gain factor to the predicted insulin output level to determine a patient insulin deficiency level, and calculate a control signal for controlling the insulin output level of the insulin pump based on the patient insulin deficiency level. Methods are provided for optimising the gain factor based on the historical data in relation to the patient.
    Type: Application
    Filed: August 9, 2012
    Publication date: February 14, 2013
    Applicant: Gene Onyx Limited
    Inventors: Christofer TOUMAZOU, Pantelis GEORGIOU, Pau Herrero VINAS, Calvin SIM